AbbVie Inc. (ABBV) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $61.16B | +8.6% |
| 2024 | $56.33B | +3.7% |
| 2023 | $54.32B | -6.4% |
| 2022 | $58.05B | +3.3% |
| 2021 | $56.20B | +22.7% |
| 2020 | $45.80B | +37.7% |
| 2019 | $33.27B | +1.6% |
| 2018 | $32.75B | +16.1% |
| 2017 | $28.22B | +10.1% |
| 2016 | $25.64B | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $61.16B | +8.6% |
| 2024 | $56.33B | +3.7% |
| 2023 | $54.32B | -6.4% |
| 2022 | $58.05B | +3.3% |
| 2021 | $56.20B | +22.7% |
| 2020 | $45.80B | +37.7% |
| 2019 | $33.27B | +1.6% |
| 2018 | $32.75B | +16.1% |
| 2017 | $28.22B | +10.1% |
| 2016 | $25.64B | — |